Prediabetes and Risk for Cardiac Death Among Patients With Coronary Artery Disease: The ARTEMIS Study.

Antti M KiviniemiE Samuli LepojärviMikko P TulppoOlli-Pekka PiiraTuomas V KenttäJuha S PerkiömäkiOlavi H UkkolaRobert J MyerburgHeikki V HuikuriHeikki V Huikuri

Published in: Diabetes care (2019)

Cardiac mortality or incidence of MACE in patients with CAD with prediabetes (i.e., IGT or IFG after revascularization, optimal medical therapy, or both) does not differ from those values in patients with normal glycemic status.

Keyphrases

left ventricular
risk factors
type diabetes
coronary artery disease
healthcare
cardiovascular events
percutaneous coronary intervention
stem cells
adipose tissue
glycemic control
skeletal muscle
weight loss
replacement therapy